Dysregulation of FBW7 in malignant lymphoproliferative disorders

Front Oncol. 2022 Nov 9:12:988138. doi: 10.3389/fonc.2022.988138. eCollection 2022.

Abstract

The ubiquitin-proteasome system (UPS) is involved in various aspects of cell processes, including cell proliferation, differentiation, and cell cycle progression. F-box and WD repeat domain-containing protein 7 (FBW7), as a key component of UPS proteins and a critical tumor suppressor in human cancers, controls proteasome-mediated degradation by ubiquitinating oncoproteins such as c-Myc, Mcl-1, cyclin E, and Notch. It also plays a role in the development of various cancers, including solid and hematological malignancies, such as T-cell acute lymphoblastic leukemia, diffuse large B-cell lymphoma, and multiple myeloma. This comprehensive review emphasizes the functions, substrates, and expression of FBW7 in malignant lymphoproliferative disorders.

Keywords: FBW7; Notch; c-Myc; lymphoproliferative disorders; ubiquitin.

Publication types

  • Review